Vestal Point Capital, LP Immatics N.V. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Immatics N.V. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,750,000 shares of IMTX stock, worth $25.7 Million. This represents 2.38% of its overall portfolio holdings.
Number of Shares
2,750,000
Previous 1,200,000
129.17%
Holding current value
$25.7 Million
Previous $12.6 Billion
153.37%
% of portfolio
2.38%
Previous 1.04%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
100Shares Held
76.8MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$93.3 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$89 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$75.4 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$69.4 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$60.1 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $711M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...